# C_2009288EN.01000101.xml

| 27.11.2009 | EN | Official Journal of the European Union | C 288/1 |
| --- | --- | --- | --- |

27.11.2009

EN

Official Journal of the European Union

C 288/1

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 October 2009 to 31 October 2009

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
   (1)
  )

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council

1

)

2009/C 288/01

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1.10.2009 | Onglyza | Saxagliptin | Bristol Myers Squibb/AstraZeneca EEIG, Bristol Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom | EU/1/09/545/001-010 | Film-coated tablet | A10BH03 | 5.10.2009 |
| 1.10.2009 | Cimzia | certolizumab pegol | UCB Pharma SA., Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef, 60, Brussel 1070, België | EU/1/09/544/001-002 | Solution for injection | L04AB05 | 6.10.2009 |
| 1.10.2009 | Simponi | golimumab | Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland | EU/1/09/546/001-004 | Solution for injection in pre-filled pen | L04AB06 | 6.10.2009 |
| 5.10.2009 | ChondroCelect | Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins | TiGenix NV, Romeinse straat 12/2, B-3001 Leuven, België | EU/1/09/563/001 | Implantation suspension | Non applicable | 7.10.2009 |
| 14.10.2009 | Enyglid | Repaglinide | KRKA, d. d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/09/580/001-018 | Tablet | A10B X02 | 16.10.2009 |
| 15.10.2009 | Resolor | prucalopride | Movetis NV, Veedijk 58, B-2300 Turnhout, België | EU/1/09/581/001-002 | Film-coated tablets | A03AE04 | 19.10.2009 |
| 15.10.2009 | Imprida HCT | amlodipine besylate / valsartan / hydrochlorothiazide | Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/09/570/001-060 | Film-coated tablet | C09DX01 | 19.10.2009 |
| 16.10.2009 | Clopidogrel MYLAN Pharma | Clopidogrel | Mylan S.A.S, 117 allee des Parcs, 69800 Saint Priest, France | EU/1/09/568/001-018 | Film-coated tablet | B01AC-04 | 20.10.2009 |
| 16.10.2009 | PANDEMIC INFLUENZA VACCINE H5N1 BAXTER | Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated) | Baxter AG, Industriestraße 67, A - 1221 Wien, Österreich | EU/1/09/571/001 | Suspension for injection | J07BB01 | 20.10.2009 |
| 16.10.2009 | Exforge HCT | amlodipine besylate / valsartan / hydrochlorothiazide | Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/09/569/001-060 | Film-coated tablet | C09DX01 | 20.10.2009 |
| 16.10.2009 | ALENDRONATE SODIUM AND COLECALCIFEROL, MSD | alendronic acid / colecalciferol | Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/09/572/001-009 | Tablet | M05BB03 | 20.10.2009 |
| 19.10.2009 | Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals | Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) A/VietNam/1194/2004 NIBRG-14 | GlaxoSmithKline Biologicals s.a., rue de l'Institut 89, 1330 Rixensart, Belgique | EU/1/09/578/001 | Suspension and Emulsion for emulsion for injection | J07BB02 | 21.10.2009 |
| 19.10.2009 | Foclivia | A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen | Novartis Vaccines and Diagnostics S.r.l., Via Fiorentina, 1 - Siena, Italia | EU/1/09/577/001-004 | Suspension for injection | J07BB02 | 21.10.2009 |
| 23.10.2009 | Lamivudine Teva | Lamivudine | Teva Pharma B.V., Computerweg 10, 3542 DR Utrecht, Nederland | EU/1/09/566/001-005 | Film-coated tablet | J05AF05 | 27.10.2009 |
| 23.10.2009 | Biopoin | epoetin theta | CT Arzneimittel GmbH, Lengeder Straße 42a, D-13407 Berlin, Deutschland | EU/1/09/565/001-028 | Solution for injection | B03XA01 | 27.10.2009 |
| 23.10.2009 | ARCALYST | Rilonacept | Regeneron UK Limited, 40 Bank Street, E14 5DS London, United Kingdom | EU/1/09/582/001 | Powder and solvent for solution for injection | L04AC04 | 27.10.2009 |
| 23.10.2009 | ILARIS | Canakinumab | Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/09/564/001-002 | Powder for solution for injection | L04AC08 | 27.10.2009 |
| 29.10.2009 | Eporatio | epoetin theta | ratiopharm GmbH, Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/09/573/001-028 | Solution for injection | B03XA01 | 2.11.2009 |
| 30.10.2009 | Irbesartan Teva | Irbesartan | Teva Pharma B.V., Computerweg 10, 3542 DR Utrecht, Nederland | EU/1/09/576/001-039 | Film-coated tablet | C09C A04 | 4.11.2009 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

1.10.2009

Onglyza

Saxagliptin

Bristol Myers Squibb/AstraZeneca EEIG, Bristol Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom

EU/1/09/545/001-010

Film-coated tablet

A10BH03

5.10.2009

1.10.2009

Cimzia

certolizumab pegol

UCB Pharma SA., Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef, 60, Brussel 1070, België

EU/1/09/544/001-002

Solution for injection

L04AB05

6.10.2009

1.10.2009

Simponi

golimumab

Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/09/546/001-004

Solution for injection in pre-filled pen

L04AB06

6.10.2009

5.10.2009

ChondroCelect

Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins

TiGenix NV, Romeinse straat 12/2, B-3001 Leuven, België

EU/1/09/563/001

Implantation suspension

Non applicable

7.10.2009

14.10.2009

Enyglid

Repaglinide

KRKA, d. d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/580/001-018

Tablet

A10B X02

16.10.2009

15.10.2009

Resolor

prucalopride

Movetis NV, Veedijk 58, B-2300 Turnhout, België

EU/1/09/581/001-002

Film-coated tablets

A03AE04

19.10.2009

15.10.2009

Imprida HCT

amlodipine besylate / valsartan / hydrochlorothiazide

Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/570/001-060

Film-coated tablet

C09DX01

19.10.2009

16.10.2009

Clopidogrel MYLAN Pharma

Clopidogrel

Mylan S.A.S, 117 allee des Parcs, 69800 Saint Priest, France

EU/1/09/568/001-018

Film-coated tablet

B01AC-04

20.10.2009

16.10.2009

PANDEMIC INFLUENZA VACCINE H5N1 BAXTER

Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)

Baxter AG, Industriestraße 67, A - 1221 Wien, Österreich

EU/1/09/571/001

Suspension for injection

J07BB01

20.10.2009

16.10.2009

Exforge HCT

amlodipine besylate / valsartan / hydrochlorothiazide

Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/569/001-060

Film-coated tablet

C09DX01

20.10.2009

16.10.2009

ALENDRONATE SODIUM AND COLECALCIFEROL, MSD

alendronic acid / colecalciferol

Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/09/572/001-009

Tablet

M05BB03

20.10.2009

19.10.2009

Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals

Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) A/VietNam/1194/2004 NIBRG-14

GlaxoSmithKline Biologicals s.a., rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/09/578/001

Suspension and Emulsion for emulsion for injection

J07BB02

21.10.2009

19.10.2009

Foclivia

A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen

Novartis Vaccines and Diagnostics S.r.l., Via Fiorentina, 1 - Siena, Italia

EU/1/09/577/001-004

Suspension for injection

J07BB02

21.10.2009

23.10.2009

Lamivudine Teva

Lamivudine

Teva Pharma B.V., Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/566/001-005

Film-coated tablet

J05AF05

27.10.2009

23.10.2009

Biopoin

epoetin theta

CT Arzneimittel GmbH, Lengeder Straße 42a, D-13407 Berlin, Deutschland

EU/1/09/565/001-028

Solution for injection

B03XA01

27.10.2009

23.10.2009

ARCALYST

Rilonacept

Regeneron UK Limited, 40 Bank Street, E14 5DS London, United Kingdom

EU/1/09/582/001

Powder and solvent for solution for injection

L04AC04

27.10.2009

23.10.2009

ILARIS

Canakinumab

Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/564/001-002

Powder for solution for injection

L04AC08

27.10.2009

29.10.2009

Eporatio

epoetin theta

ratiopharm GmbH, Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/09/573/001-028

Solution for injection

B03XA01

2.11.2009

30.10.2009

Irbesartan Teva

Irbesartan

Teva Pharma B.V., Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/576/001-039

Film-coated tablet

C09C A04

4.11.2009

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

Modification of a marketing authorization (Article 13 of Regulation (EC) No

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 1.10.2009 | Epoetin alfa Hexal | Hexal AG., Industriestrasse 25, D-83607 Holzkirchen, Deutschland | EU/1/07/411/021-026 | 5.10.2009 |
| 1.10.2009 | Mixtard | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/02/231/001-037 | 5.10.2009 |
| 1.10.2009 | Protaphane | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/02/234/001-017 | 5.10.2009 |
| 1.10.2009 | Insulatard | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/02/233/001-017 | 5.10.2009 |
| 1.10.2009 | Actrapid | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/02/230/001-017 | 5.10.2009 |
| 1.10.2009 | Actraphane | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/02/229/001-037 | 6.10.2009 |
| 1.10.2009 | Binocrit | Sandoz GmbH, Biochemiestrasse 10, Kundl 6250, Österreich | EU/1/07/410/021-026 | 5.10.2009 |
| 2.10.2009 | Tasmar | Meda AB, Pipers väg 2A, Solna 170 09, Sverige | EU/1/97/044/001-008 | 6.10.2009 |
| 6.10.2009 | CELVAPAN | Baxter AG, Industriestraße 67, 1221 Wien, Österreich | EU/1/08/506/001 | 8.10.2009 |
| 7.10.2009 | Agenerase | Glaxo Group Limited, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom | EU/1/00/148/001-004 | 9.10.2009 |
| 7.10.2009 | IntronA | Schering Plough Europe, Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België | EU/1/99/127/031-039 | 9.10.2009 |
| 8.10.2009 | Mirapexin | Boehringer Ingelheim International GmbH, Binger Strasse 173- D - 55216 Ingelheim am Rhein, Deutschland | EU/1/97/051/013-027 | 12.10.2009 |
| 8.10.2009 | Sifrol | Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216 Ingelheim am Rhein, Deutschland | EU/1/97/050/013-027 | 12.10.2009 |
| 8.10.2009 | Nplate | Amgen Europe B.V., Minervum 7061, 4817 ZK Breda, Nederland | EU/1/08/497/001-004 | 12.10.2009 |
| 8.10.2009 | Circadin | RAD Neurim Pharmaceuticals EEC Limited, One Forbury Square, The Forbury, Reading, Berkshire RG1 3EB, United Kingdom | EU/1/07/392/001-002 | 12.10.2009 |
| 13.10.2009 | NovoMix | Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/00/142/004-005
  EU/1/00/142/009-022 | 15.10.2009 |
| 13.10.2009 | Olanzapine Neopharma | Neopharma Limited, 57 High Street, Odiham, Hampshire RG29 1LF, United Kingdom | EU/1/07/426/001-011 | 15.10.2009 |
| 13.10.2009 | CellCept | Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/96/005/001-006 | 15.10.2009 |
| 13.10.2009 | Kinzalkomb | Bayer Schering Pharma AG, D-13342 Berlin, Deutschland | EU/1/02/214/001-015 | 15.10.2009 |
| 14.10.2009 | alli | Glaxo Group Limited, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom | EU/1/07/401/001-006 | 16.10.2009 |
| 14.10.2009 | Onsenal | Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/03/259/001-006 | 16.10.2009 |
| 14.10.2009 | PritorPlus | Bayer Schering Pharma AG, 13342 Berlin, Deutschland | EU/1/02/215/001-021 | 16.10.2009 |
| 14.10.2009 | Ammonaps | Swedish Orphan International AB, Drottninggatan 98, 111 60 Stockholm, Sverige | EU/1/99/120/001-004 | 19.10.2009 |
| 15.10.2009 | Nexavar | Bayer Schering Pharma AG, 13342 Berlin, Deutschland | EU/1/06/342/001 | 19.10.2009 |
| 16.10.2009 | Helixate NexGen | Bayer Schering Pharma AG, 13342 Berlin, Deutschland | EU/1/00/144/001-004 | 20.10.2009 |
| 16.10.2009 | Aptivus | Boehringer Ingelheim International GmbH, Binger Strasse 173- 55216 Ingelheim am Rhein, Deutschland | EU/1/05/315/001-002 | 20.10.2009 |
| 16.10.2009 | KOGENATE Bayer | Bayer Schering Pharma AG, 13342 Berlin, Deutschland | EU/1/00/143/001-011 | 20.10.2009 |
| 19.10.2009 | Thalidomide Celgene | Celgene Europe Limited, Riverside House, Riverside Walk, Windsor SL4 1NA, United Kingdom | EU/1/08/443/001 | 21.10.2009 |
| 19.10.2009 | Ribavirin Teva Pharma BV | Teva Pharma B.V., Computerweg 10, 3542 DR Utrecht, Nederland | EU/1/09/527/001-016 | 21.10.2009 |
| 19.10.2009 | Revlimid | Celgene Europe Limited, Riverside House, Riverside Walk, Windsor, Berkshire SL4 1NA, United Kingdom | EU/1/07/391/001-004 | 21.10.2009 |
| 19.10.2009 | Prepandrix | GlaxoSmithKline Biologicals s.a., rue de l'Institut 89, Rixensart, 1330 Belgique | EU/1/08/453/002 | 21.10.2009 |
| 19.10.2009 | Wilzin | Orphan Europe S.a.r.l., Immeuble Le Wilson, 70 Avenue du Général de Gaulle, 92800 Puteaux, France | EU/1/04/286/001-002 | 21.10.2009 |
| 19.10.2009 | Olanzapine Teva | Teva Pharma B.V., Computerweg 10, DR Utrecht 3542,Nederland | EU/1/07/427/001-057 | 21.10.2009 |
| 20.10.2009 | Vidaza | Celgene Europe Ltd, Riverside House, Riverside Walk, Windsor, SL4 1NA, United Kingdom | EU/1/08/488/001 | 22.10.2009 |
| 21.10.2009 | Xarelto | Bayer Schering Pharma AG, 13342 Berlin, Deutschland | EU/1/08/472/001-008 | 23.10.2009 |
| 21.10.2009 | Metalyse | Boehringer Ingelheim International GmbH, Binger Strasse 173- 55216 Ingelheim am Rhein, Deutschland | EU/1/00/169/004-006 | 23.10.2009 |
| 21.10.2009 | Filgrastim Hexal | HEXAL AG, Industriestrasse 25, 83607 Holzkirchen, Deutschland | EU/1/08/496/001-008 | 26.10.2009 |
| 21.10.2009 | Zarzio | Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Österreich | EU/1/08/495/001-008 | 23.10.2009 |
| 23.10.2009 | Rebif | Merck Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom | EU/1/98/063/001-010 | 27.10.2009 |
| 23.10.2009 | Prezista | Janssen-Cilag International NV, Turnhoutseweg, 30 - 2340 Beerse – België | EU/1/06/380/001-005 | 27.10.2009 |
| 23.10.2009 | Olanzapine Mylan | Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom | EU/1/08/475/001-034 | 27.10.2009 |
| 23.10.2009 | Norvir | Abbott Laboratories Ltd, Queenborough, Kent ME11 5EL, United Kingdom | EU/1/96/016/001
  EU/1/96/016/003-004 | 27.10.2009 |
| 23.10.2009 | PEGASYS | Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/02/221/001-010 | 27.10.2009 |
| 23.10.2009 | Invanz | Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/02/216/001-002 | 27.10.2009 |
| 23.10.2009 | Procoralan | Les Laboratoires Servier, 22, rue Garnier, 92200 Neuilly-sur-Seine, France | EU/1/05/316/001-014 | 27.10.2009 |
| 23.10.2009 | Teslascan | GE Healthcare AS, Nycoveien 1-2, P.O.Box 4220 Nydalen, N-0401 Oslo, Norway | EU/1/97/040/001-002 | 27.10.2009 |
| 23.10.2009 | Vistide | Gilead Sciences International Limited, Cambridge, CB21 6GT, United Kingdom | EU/1/97/037/001 | 27.10.2009 |
| 23.10.2009 | RotaTeq | Sanofi Pasteur MSD, SNC, 8, rue Jonas Salk, Lyon 69007, France | EU/1/06/348/001-002 | 27.10.2009 |
| 23.10.2009 | Tamiflu | Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/02/222/001-004 | 27.10.2009 |
| 23.10.2009 | Corlentor | Les Laboratoires Servier, 22, rue Garnier, 92200 Neuilly-sur-Seine, France | EU/1/05/317/001-014 | 27.10.2009 |
| 23.10.2009 | Neulasta | Amgen Europe B.V., Minervum 7061, 4817 ZK Breda, Nederland | EU/1/02/227/001-004 | 27.10.2009 |
| 23.10.2009 | Ellaone | Laboratoire HRA Pharma, 15, rue Béranger, 75003 Paris, France | EU/1/09/522/001 | 27.10.2009 |
| 28.10.2009 | Xelevia | Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/07/382/001-018 | 30.10.2009 |
| 28.10.2009 | TESAVEL | Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/07/435/001-018 | 30.10.2009 |
| 28.10.2009 | Pradaxa | Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216 Ingelheim am Rhein, Deutschland | EU/1/08/442/001-008 | 2.11.2009 |
| 28.10.2009 | Aranesp | Amgen Europe B.V., Minervum 7061, 4817 ZK Breda, Nederland | EU/1/01/185/001-022
  EU/1/01/185/031-099 | 30.10.2009 |
| 28.10.2009 | Zerit | Bristol-Myers Squibb Pharma EEIG, Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom | EU/1/96/009/001-009 | 30.10.2009 |
| 28.10.2009 | Arava | Sanofi-Aventis Deutschland GmbH, 65926 Frankfurt am Main, Deutschland | EU/1/99/118/001-010 | 30.10.2009 |
| 28.10.2009 | Yondelis | Pharma Mar, S.A., Avda. de los Reyes 1, Polígono Industrial La Mina, 28770 Colmenar Viejo (Madrid), España | EU/1/07/417/001-002 | 30.10.2009 |
| 28.10.2009 | Myozyme | Genzyme Europe B.V., Gooimeer 10, 1411 DD Naarden, Nederland | EU/1/06/333/001-003 | 2.11.2009 |
| 28.10.2009 | SUTENT | Pfizer Ltd, Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom | EU/1/06/347/001-008 | 30.10.2009 |
| 28.10.2009 | Integrilin | Glaxo Group Ltd, Greenford, Middlesex, UB6 ONN, United Kingdom | EU/1/99/109/001-002 | 30.10.2009 |
| 28.10.2009 | BeneFIX | Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom | EU/1/97/047/001-007 | 30.10.2009 |
| 28.10.2009 | RoActemra | Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/08/492/001-006 | 30.10.2009 |
| 28.10.2009 | Beromun | Boehringer Ingelheim International GmbH, Binger Strasse 173- 55216 Ingelheim am Rhein, Deutschland | EU/1/99/097/001 | 2.11.2009 |
| 28.10.2009 | Epivir | Glaxo Group Ltd., Greenford Road, Greenford, Middlesex UB6 0NN, United Kingdom | EU/1/96/015/001-005 | 30.10.2009 |
| 28.10.2009 | IXIARO | Intercell AG, Campus Vienna Biocenter 3 A-1030 Wien, Österreich | EU/1/08/501/001-002 | 30.10.2009 |
| 28.10.2009 | Efficib | Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/08/457/001-016 | 30.10.2009 |
| 28.10.2009 | Janumet | Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/08/455/001-016 | 30.10.2009 |
| 28.10.2009 | Noxafil | SP Europe, Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België | EU/1/05/320/001 | 30.10.2009 |
| 28.10.2009 | Velcade | Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, België | EU/1/04/274/001-002 | 30.10.2009 |
| 28.10.2009 | Zostavax | Sanofi Pasteur MSD, SNC, 8, rue Jonas Salk, 69007 Lyon, France | EU/1/06/341/001-013 | 30.10.2009 |
| 28.10.2009 | Velmetia | Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/08/456/001-016 | 30.10.2009 |
| 29.10.2009 | Sebivo | Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/07/388/001-003 | 2.11.2009 |
| 29.10.2009 | ADROVANCE | Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/06/364/001-009 | 2.11.2009 |
| 29.10.2009 | Remicade | Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland | EU/1/99/116/001-005 | 2.11.2009 |
| 29.10.2009 | INOmax | INO Therapeutics AB, SE-181 81 Lidingö, Sverige | EU/1/01/194/001-002 | 3.11.2009 |
| 30.10.2009 | Xagrid | Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom | EU/1/04/295/001 | 4.11.2009 |
| 30.10.2009 | Zalasta | KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/07/415/001-056 | 4.11.2009 |
| 30.10.2009 | Insulin Human Winthrop | Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Deutschland | EU/1/06/368/001-168 | 4.11.2009 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

1.10.2009

Epoetin alfa Hexal

Hexal AG., Industriestrasse 25, D-83607 Holzkirchen, Deutschland

EU/1/07/411/021-026

5.10.2009

1.10.2009

Mixtard

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/231/001-037

5.10.2009

1.10.2009

Protaphane

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/234/001-017

5.10.2009

1.10.2009

Insulatard

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/233/001-017

5.10.2009

1.10.2009

Actrapid

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/230/001-017

5.10.2009

1.10.2009

Actraphane

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/229/001-037

6.10.2009

1.10.2009

Binocrit

Sandoz GmbH, Biochemiestrasse 10, Kundl 6250, Österreich

EU/1/07/410/021-026

5.10.2009

2.10.2009

Tasmar

Meda AB, Pipers väg 2A, Solna 170 09, Sverige

EU/1/97/044/001-008

6.10.2009

6.10.2009

CELVAPAN

Baxter AG, Industriestraße 67, 1221 Wien, Österreich

EU/1/08/506/001

8.10.2009

7.10.2009

Agenerase

Glaxo Group Limited, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/00/148/001-004

9.10.2009

7.10.2009

IntronA

Schering Plough Europe, Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België

EU/1/99/127/031-039

9.10.2009

8.10.2009

Mirapexin

Boehringer Ingelheim International GmbH, Binger Strasse 173- D - 55216 Ingelheim am Rhein, Deutschland

EU/1/97/051/013-027

12.10.2009

8.10.2009

Sifrol

Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/97/050/013-027

12.10.2009

8.10.2009

Nplate

Amgen Europe B.V., Minervum 7061, 4817 ZK Breda, Nederland

EU/1/08/497/001-004

12.10.2009

8.10.2009

Circadin

RAD Neurim Pharmaceuticals EEC Limited, One Forbury Square, The Forbury, Reading, Berkshire RG1 3EB, United Kingdom

EU/1/07/392/001-002

12.10.2009

13.10.2009

NovoMix

Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/00/142/004-005

EU/1/00/142/009-022

15.10.2009

13.10.2009

Olanzapine Neopharma

Neopharma Limited, 57 High Street, Odiham, Hampshire RG29 1LF, United Kingdom

EU/1/07/426/001-011

15.10.2009

13.10.2009

CellCept

Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/96/005/001-006

15.10.2009

13.10.2009

Kinzalkomb

Bayer Schering Pharma AG, D-13342 Berlin, Deutschland

EU/1/02/214/001-015

15.10.2009

14.10.2009

alli

Glaxo Group Limited, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/07/401/001-006

16.10.2009

14.10.2009

Onsenal

Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/03/259/001-006

16.10.2009

14.10.2009

PritorPlus

Bayer Schering Pharma AG, 13342 Berlin, Deutschland

EU/1/02/215/001-021

16.10.2009

14.10.2009

Ammonaps

Swedish Orphan International AB, Drottninggatan 98, 111 60 Stockholm, Sverige

EU/1/99/120/001-004

19.10.2009

15.10.2009

Nexavar

Bayer Schering Pharma AG, 13342 Berlin, Deutschland

EU/1/06/342/001

19.10.2009

16.10.2009

Helixate NexGen

Bayer Schering Pharma AG, 13342 Berlin, Deutschland

EU/1/00/144/001-004

20.10.2009

16.10.2009

Aptivus

Boehringer Ingelheim International GmbH, Binger Strasse 173- 55216 Ingelheim am Rhein, Deutschland

EU/1/05/315/001-002

20.10.2009

16.10.2009

KOGENATE Bayer

Bayer Schering Pharma AG, 13342 Berlin, Deutschland

EU/1/00/143/001-011

20.10.2009

19.10.2009

Thalidomide Celgene

Celgene Europe Limited, Riverside House, Riverside Walk, Windsor SL4 1NA, United Kingdom

EU/1/08/443/001

21.10.2009

19.10.2009

Ribavirin Teva Pharma BV

Teva Pharma B.V., Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/527/001-016

21.10.2009

19.10.2009

Revlimid

Celgene Europe Limited, Riverside House, Riverside Walk, Windsor, Berkshire SL4 1NA, United Kingdom

EU/1/07/391/001-004

21.10.2009

19.10.2009

Prepandrix

GlaxoSmithKline Biologicals s.a., rue de l'Institut 89, Rixensart, 1330 Belgique

EU/1/08/453/002

21.10.2009

19.10.2009

Wilzin

Orphan Europe S.a.r.l., Immeuble Le Wilson, 70 Avenue du Général de Gaulle, 92800 Puteaux, France

EU/1/04/286/001-002

21.10.2009

19.10.2009

Olanzapine Teva

Teva Pharma B.V., Computerweg 10, DR Utrecht 3542,Nederland

EU/1/07/427/001-057

21.10.2009

20.10.2009

Vidaza

Celgene Europe Ltd, Riverside House, Riverside Walk, Windsor, SL4 1NA, United Kingdom

EU/1/08/488/001

22.10.2009

21.10.2009

Xarelto

Bayer Schering Pharma AG, 13342 Berlin, Deutschland

EU/1/08/472/001-008

23.10.2009

21.10.2009

Metalyse

Boehringer Ingelheim International GmbH, Binger Strasse 173- 55216 Ingelheim am Rhein, Deutschland

EU/1/00/169/004-006

23.10.2009

21.10.2009

Filgrastim Hexal

HEXAL AG, Industriestrasse 25, 83607 Holzkirchen, Deutschland

EU/1/08/496/001-008

26.10.2009

21.10.2009

Zarzio

Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Österreich

EU/1/08/495/001-008

23.10.2009

23.10.2009

Rebif

Merck Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/98/063/001-010

27.10.2009

23.10.2009

Prezista

Janssen-Cilag International NV, Turnhoutseweg, 30 - 2340 Beerse – België

EU/1/06/380/001-005

27.10.2009

23.10.2009

Olanzapine Mylan

Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

EU/1/08/475/001-034

27.10.2009

23.10.2009

Norvir

Abbott Laboratories Ltd, Queenborough, Kent ME11 5EL, United Kingdom

EU/1/96/016/001

EU/1/96/016/003-004

27.10.2009

23.10.2009

PEGASYS

Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/221/001-010

27.10.2009

23.10.2009

Invanz

Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/02/216/001-002

27.10.2009

23.10.2009

Procoralan

Les Laboratoires Servier, 22, rue Garnier, 92200 Neuilly-sur-Seine, France

EU/1/05/316/001-014

27.10.2009

23.10.2009

Teslascan

GE Healthcare AS, Nycoveien 1-2, P.O.Box 4220 Nydalen, N-0401 Oslo, Norway

EU/1/97/040/001-002

27.10.2009

23.10.2009

Vistide

Gilead Sciences International Limited, Cambridge, CB21 6GT, United Kingdom

EU/1/97/037/001

27.10.2009

23.10.2009

RotaTeq

Sanofi Pasteur MSD, SNC, 8, rue Jonas Salk, Lyon 69007, France

EU/1/06/348/001-002

27.10.2009

23.10.2009

Tamiflu

Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/222/001-004

27.10.2009

23.10.2009

Corlentor

Les Laboratoires Servier, 22, rue Garnier, 92200 Neuilly-sur-Seine, France

EU/1/05/317/001-014

27.10.2009

23.10.2009

Neulasta

Amgen Europe B.V., Minervum 7061, 4817 ZK Breda, Nederland

EU/1/02/227/001-004

27.10.2009

23.10.2009

Ellaone

Laboratoire HRA Pharma, 15, rue Béranger, 75003 Paris, France

EU/1/09/522/001

27.10.2009

28.10.2009

Xelevia

Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/382/001-018

30.10.2009

28.10.2009

TESAVEL

Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/435/001-018

30.10.2009

28.10.2009

Pradaxa

Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/08/442/001-008

2.11.2009

28.10.2009

Aranesp

Amgen Europe B.V., Minervum 7061, 4817 ZK Breda, Nederland

EU/1/01/185/001-022

EU/1/01/185/031-099

30.10.2009

28.10.2009

Zerit

Bristol-Myers Squibb Pharma EEIG, Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/96/009/001-009

30.10.2009

28.10.2009

Arava

Sanofi-Aventis Deutschland GmbH, 65926 Frankfurt am Main, Deutschland

EU/1/99/118/001-010

30.10.2009

28.10.2009

Yondelis

Pharma Mar, S.A., Avda. de los Reyes 1, Polígono Industrial La Mina, 28770 Colmenar Viejo (Madrid), España

EU/1/07/417/001-002

30.10.2009

28.10.2009

Myozyme

Genzyme Europe B.V., Gooimeer 10, 1411 DD Naarden, Nederland

EU/1/06/333/001-003

2.11.2009

28.10.2009

SUTENT

Pfizer Ltd, Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/06/347/001-008

30.10.2009

28.10.2009

Integrilin

Glaxo Group Ltd, Greenford, Middlesex, UB6 ONN, United Kingdom

EU/1/99/109/001-002

30.10.2009

28.10.2009

BeneFIX

Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/97/047/001-007

30.10.2009

28.10.2009

RoActemra

Roche Registration Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/08/492/001-006

30.10.2009

28.10.2009

Beromun

Boehringer Ingelheim International GmbH, Binger Strasse 173- 55216 Ingelheim am Rhein, Deutschland

EU/1/99/097/001

2.11.2009

28.10.2009

Epivir

Glaxo Group Ltd., Greenford Road, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/96/015/001-005

30.10.2009

28.10.2009

IXIARO

Intercell AG, Campus Vienna Biocenter 3 A-1030 Wien, Österreich

EU/1/08/501/001-002

30.10.2009

28.10.2009

Efficib

Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/457/001-016

30.10.2009

28.10.2009

Janumet

Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/455/001-016

30.10.2009

28.10.2009

Noxafil

SP Europe, Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België

EU/1/05/320/001

30.10.2009

28.10.2009

Velcade

Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, België

EU/1/04/274/001-002

30.10.2009

28.10.2009

Zostavax

Sanofi Pasteur MSD, SNC, 8, rue Jonas Salk, 69007 Lyon, France

EU/1/06/341/001-013

30.10.2009

28.10.2009

Velmetia

Merck Sharp & Dohme Ltd., Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/456/001-016

30.10.2009

29.10.2009

Sebivo

Novartis Europharm Limited, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/388/001-003

2.11.2009

29.10.2009

ADROVANCE

Merck Sharp & Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/06/364/001-009

2.11.2009

29.10.2009

Remicade

Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-005

2.11.2009

29.10.2009

INOmax

INO Therapeutics AB, SE-181 81 Lidingö, Sverige

EU/1/01/194/001-002

3.11.2009

30.10.2009

Xagrid

Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom

EU/1/04/295/001

4.11.2009

30.10.2009

Zalasta

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/07/415/001-056

4.11.2009

30.10.2009

Insulin Human Winthrop

Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Deutschland

EU/1/06/368/001-168

4.11.2009

—   Lift of suspension of a marketing authorization (Article 20 of Regulation (EC) No 726/2004)

Lift of suspension of a marketing authorization (Article 20 of Regulation (EC) No

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 8.10.2009 | Optison | GE Healthcare AS, Nycoveien 1-2, P.O.Box 4220 Nydalen, N-0401 Oslo, Norway | EU/1/98/065/001-002 | 12.10.2009 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

8.10.2009

Optison

GE Healthcare AS, Nycoveien 1-2, P.O.Box 4220 Nydalen, N-0401 Oslo, Norway

EU/1/98/065/001-002

12.10.2009

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

Modification of a marketing authorization (Article 38 of Regulation (EC) No

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 1.10.2009 | Oxyglobin | Biopure Netherlands B.V., Parnassustoren, Locatellikade 1, 1076 AZ Amsterdam, Nederland | EU/2/99/015/001-002 | 5.10.2009 |
| 1.10.2009 | Stronghold | Pfizer Ltd, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/2/99/014/001-012 | 5.10.2009 |
| 6.10.2009 | Nobilis Influenza H5N2 | Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland | EU/2/06/061/001-004 | 8.10.2009 |
| 8.10.2009 | Naxcel | Pfizer Ltd, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/2/05/053/003 | 12.10.2009 |
| 8.10.2009 | Rheumocam | Chanelle Pharmaceuticals Manufacturing Limited, Loughrea, Co. Galway, IRELAND | EU/2/07/078/005-008 | 12.10.2009 |
| 8.10.2009 | Meloxidyl | CEVA SANTE ANIMALE, Z.I. la Ballastière, 33500 Libourne, France | EU/2/06/070/004 | 12.10.2009 |
| 21.10.2009 | Suprelorin | VIRBAC S.A., 1ère Avenue 2065 m L.I.D. - 06516 Carros – France | EU/2/07/072/001-002 | 23.10.2009 |
| 30.10.2009 | Easotic | VIRBAC S.A., 1ère Avenue 2065 m L.I.D. - 06516 Carros – France | EU/2/08/085/001 | 4.11.2009 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

1.10.2009

Oxyglobin

Biopure Netherlands B.V., Parnassustoren, Locatellikade 1, 1076 AZ Amsterdam, Nederland

EU/2/99/015/001-002

5.10.2009

1.10.2009

Stronghold

Pfizer Ltd, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/2/99/014/001-012

5.10.2009

6.10.2009

Nobilis Influenza H5N2

Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/06/061/001-004

8.10.2009

8.10.2009

Naxcel

Pfizer Ltd, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/2/05/053/003

12.10.2009

8.10.2009

Rheumocam

Chanelle Pharmaceuticals Manufacturing Limited, Loughrea, Co. Galway, IRELAND

EU/2/07/078/005-008

12.10.2009

8.10.2009

Meloxidyl

CEVA SANTE ANIMALE, Z.I. la Ballastière, 33500 Libourne, France

EU/2/06/070/004

12.10.2009

21.10.2009

Suprelorin

VIRBAC S.A., 1ère Avenue 2065 m L.I.D. - 06516 Carros – France

EU/2/07/072/001-002

23.10.2009

30.10.2009

Easotic

VIRBAC S.A., 1ère Avenue 2065 m L.I.D. - 06516 Carros – France

EU/2/08/085/001

4.11.2009

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7, Westferry Circus, Canary Wharf |
| London E14 4HB |
| UNITED KINGDOM |

The European Medicines Agency

7, Westferry Circus, Canary Wharf

London E14 4HB

UNITED KINGDOM

---

(1)  OJ L 136 of 30.4.2004, p. 1.

1

---